Indication
Ecthyma gangrenosum
Ecthyma gangrenosum is a rare, severe cutaneous manifestation typically associated with systemic bacteremia, classic to *Pseudomonas aeruginosa* infection, though occasionally caused by other opportunistic pathogens. Read more about Ecthyma gangrenosum
22 drugs 13 manufacturers
Drugs that treat it
Common Ecthyma gangrenosum therapies.
TAZICEF (ceftazidime)
TAZICEF (ceftazidime)
FORTAZ (ceftazidime)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonEcthyma gangrenosum is a rare, severe cutaneous manifestation typically associated with systemic bacteremia, classic to *Pseudomonas aeruginosa* infection, though occasionally caused by other opportunistic pathogens.
It predominantly affects the integumentary system of severely immunocompromised, neutropenic, or critically ill patients.
Pathophysiologically, hematogenous bacterial seeding leads to perivascular invasion of dermal and subcutaneous blood vessels, resulting in necrotizing vasculitis, secondary thrombosis, and localized tissue infarction.
Clinically, the condition manifests as painless erythematous macules or hemorrhagic bullae that rapidly progress into painless, punched-out necrotic ulcers covered by a central black eschar with an erythematous rim.
- nih.gov
Ecthyma gangrenosum is a rare, severe cutaneous manifestation typically associated with systemic bacteremia, classic to *Pseudomonas aeruginosa* infection, though occasionally caused by other opportunistic pathogens It predominantly affects the integumentary system of severely immunocompromised, neutropenic, or critically ill patients
- nih.gov
Ecthyma gangrenosum is a rare, severe cutaneous manifestation typically associated with systemic bacteremia, classic to *Pseudomonas aeruginosa* infection, though occasionally caused by other opportunistic pathogens Pathophysiologically, hematogenous bacterial seeding leads to perivascular invasion of dermal and subcutaneous blood vessels, resulting in necrotizing vasculitis, secondary thrombosis, and localized tissue infarction Clinically, the condition manifests as painless erythematous macule...
- pcds.org.uk
It predominantly affects the integumentary system of severely immunocompromised, neutropenic, or critically ill patients Pathophysiologically, hematogenous bacterial seeding leads to perivascular invasion of dermal and subcutaneous blood vessels, resulting in necrotizing vasculitis, secondary thrombosis, and localized tissue infarction
- nih.gov
Clinically, the condition manifests as painless erythematous macules or hemorrhagic bullae that rapidly progress into painless, punched-out necrotic ulcers covered by a central black eschar with an erythematous rim
Personalize your experience
Follow Ecthyma gangrenosum and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.